Retour
Fourchette du Jour
6,54 €
9,15 €
Fourchette 52 Semaines
1,83 €
12,43 €
Volume
86 610 892
Moyenne 50J / 200J
7,10 €
/
3,63 €
Clôture Précédente
9,40 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -21,7 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -310,2 | 3,8 |
| Rev Growth 5Y % | 231,9 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
13,50 €
+82.1%
Low: 12,00 €
High: 15,00 €
BPA Prévisionnel
-0,26 €
CA Est.
210 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,96 €
1,20 € – 2,92 €
|
3,7 B | 1 |
| FY2029 |
1,09 €
0,67 € – 1,62 €
|
2,2 B | 1 |
| FY2028 |
0,51 €
0,40 € – 0,60 €
|
1,2 B | 3 |
Points Clés
Revenue grew 231,86% annually over 5 years — strong growth
Negative free cash flow of -308,78M
PEG of 0,15 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 436,45%
Capital efficient — spends only 3,39% of revenue on capex
Croissance
Revenue Growth (5Y)
231,86%
Revenue (1Y)668,31%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-50,73%
Net Margin-310,18%
Op. Margin-226,00%
Sécurité
Debt / Equity
N/A
Current Ratio5,10
Interest Coverage-2,28
Valorisation
P/E Ratio
-21,69
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 668,31% | Revenue Growth (3Y) | 1249,57% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 231,86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 113,29M | Net Income (TTM) | -351,40M |
| ROE | N/A | ROA | -70,01% |
| Gross Margin | 99,34% | Operating Margin | -226,00% |
| Net Margin | -310,18% | Free Cash Flow (TTM) | -308,78M |
| ROIC | -50,73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5,10 |
| Interest Coverage | -2,28 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -21,69 | P/B Ratio | N/A |
| P/S Ratio | 67,29 | PEG Ratio | 0,15 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 7,62B | Enterprise Value | 8,41B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 113,29M | 14,75M | 622 000,0 | 240 000,0 | 934 000,0 |
| Net Income | -351,40M | -413,56M | -583,20M | -416,57M | -346,79M |
| EPS (Diluted) | -0,38 | -0,62 | -1,15 | -1,04 | -0,89 |
| Gross Profit | 112,54M | 14,75M | 622 000,0 | 240 000,0 | 934 000,0 |
| Operating Income | -256,03M | -344,18M | -362,25M | -351,30M | -330,28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 501,90M | 382,93M | 504,45M | 362,36M | 468,91M |
| Total Liabilities | 1,00B | 871,06M | 1,09B | 812,18M | 712,82M |
| Shareholders' Equity | -499,57M | -489,10M | -586,99M | -447,33M | -242,17M |
| Total Debt | 878,12M | 504,17M | 726,72M | 723,77M | 645,66M |
| Cash & Equivalents | 88,33M | 143,43M | 265,45M | 104,64M | 181,10M |
| Current Assets | 314,88M | 184,59M | 294,08M | 140,58M | 334,35M |
| Current Liabilities | 61,75M | 54,94M | 58,28M | 500,86M | 369,00M |